Home › NDC Lookup › RxCUI directory › RxCUI 2467575

Berotralstat 110 MG Oral Capsule [Orladeyo] — RxCUI 2467575

RxNorm drug concept · Semantic branded drug
RxCUI 2467575 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2467575
Official nameBerotralstat 110 MG Oral Capsule [Orladeyo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOrladeyo 110 MG Oral Capsule
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)980 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Berotralstat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Orladeyo is a preventive medication — it works in the background every day to reduce how often your HAE attacks happen. It blocks an enzyme in your blood called plasma kallikrein,...
  • What exactly is Orladeyo supposed to do for me?
  • No — Orladeyo is not designed or approved to treat an active attack. Taking extra doses to try to stop a flare won't help, and it's actually unsafe because higher doses can affect...
  • Can I take Orladeyo to stop an HAE attack that's happening right now?
📖 Read our full Berotralstat guide →

🕸️ Concept Web — How Berotralstat 110 MG Oral Capsule [Orladeyo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Berotralstat 110 MG Oral Capsule [Orladeyo] RxCUI 2467575

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Berotralstat 2467540
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Orladeyo 2467566
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Berotralstat Oral Capsule 2467564
    • Berotralstat Oral Product 2467562
    • Berotralstat Pill 2467563
    • Berotralstat Oral Capsule [Orladeyo] 2467568
    • Orladeyo Oral Product 2467569
    • Orladeyo Pill 2467570
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Berotralstat 110 MG Oral Capsule SCD · 2467573
  • Berotralstat 110 MG SCDC · 2467572
  • Berotralstat Oral Capsule SCDF · 2467564
  • Berotralstat Oral Product SCDG · 2467562
  • Berotralstat Pill SCDG · 2467563

Brand-Name Concepts

  • Berotralstat 110 MG [Orladeyo] SBDC · 2467574
  • Berotralstat Oral Capsule [Orladeyo] SBDF · 2467568
  • Orladeyo Oral Product SBDG · 2467569
  • Orladeyo Pill SBDG · 2467570
  • Orladeyo BN · 2467566

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 2467575 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72769-0101-01 4 DOSE PACK in 1 CARTON (72769-101-01) / 1 BLISTER PACK in... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-04
72769-0102-01 4 DOSE PACK in 1 CARTON (72769-102-01) / 1 BLISTER PACK in... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-04
72769-0111-02 4 DOSE PACK in 1 CARTON (72769-111-02) / 7 PACKET in 1 DOSE... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-12
72769-0112-02 4 DOSE PACK in 1 CARTON (72769-112-02) / 7 PACKET in 1 DOSE... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-12
72769-0113-02 4 DOSE PACK in 1 CARTON (72769-113-02) / 7 PACKET in 1 DOSE... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-12
72769-0114-02 4 DOSE PACK in 1 CARTON (72769-114-02) / 7 PACKET in 1 DOSE... Orladeyo BioCryst Pharmaceuticals, Inc. 2020-12-12
Observed labelers: BioCryst Pharmaceuticals, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.